107 related articles for article (PubMed ID: 1690252)
1. [Anti-embryoglycan antibodies detected in sera of patients with uterine cervical cancer].
Kato Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):129-35. PubMed ID: 1690252
[TBL] [Abstract][Full Text] [Related]
2. Molecular properties of F9 embryoglycan recognized by a unique antibody in sera from patients with germ cell tumors.
Kawata M; Sekiya S; Takamizawa H; Muramatsu T; Okumura K
Cancer Res; 1987 May; 47(9):2288-94. PubMed ID: 3032420
[TBL] [Abstract][Full Text] [Related]
3. Molecular properties of ECMA 2 and ECMA 3 antigens defined by monoclonal antibodies against embryonal carcinoma cells.
Ozawa M; Muramatsu T; Kemler R
J Biochem; 1985 Jan; 97(1):307-15. PubMed ID: 2581941
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
[TBL] [Abstract][Full Text] [Related]
5. [Antibodies in patients with cervicouterine carcinoma].
Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
[TBL] [Abstract][Full Text] [Related]
6. [A new serological diagnostic method for malignant ovarian tumors of germ cell origin. Detection of antibodies to large glycopeptides isolated from F9 cells].
Higaki K; Kawata M; Sekiya S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2274-82. PubMed ID: 6663135
[TBL] [Abstract][Full Text] [Related]
7. Antibody levels against alpha-galactosyl epitopes in sera of patients with squamous intraepithelial lesions and early invasive cervical carcinoma.
Tremont-Lukats IW; Avila JL; Hernández D; Vásquez J; Teixeira GM; Rojas M
Gynecol Oncol; 1997 Feb; 64(2):207-12. PubMed ID: 9038265
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
[TBL] [Abstract][Full Text] [Related]
9. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
Lindgren A; Stendahl U; Brodin T; Lundblad A; Sällström J; Busch C
Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015
[TBL] [Abstract][Full Text] [Related]
10. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to large glycopeptides in sera from patients with ovarian germ cell tumours.
Kawata M; Higaki K; Sekiya S; Takamizawa H; Muramatsu T; Okumura K
Clin Exp Immunol; 1983 Feb; 51(2):401-6. PubMed ID: 6301713
[TBL] [Abstract][Full Text] [Related]
12. [Expression of blood group antigens A, B, H, Lewis a, Lewis b, in malignant lesions of the uterine cervix].
Sasagawa T; Inoue M; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O; Nakayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):345-52. PubMed ID: 2834474
[TBL] [Abstract][Full Text] [Related]
13. [A tumor-associated antigen of cervical cancer].
Ermoshina NV; Ievleva ES; Ageenko AI; Kogan IIa; Tsukerman BG
Eksp Onkol; 1986; 8(2):48-51. PubMed ID: 3084195
[TBL] [Abstract][Full Text] [Related]
14. [A clinico-pathological implication of ABO (H) blood group substances expressed in the primary lesion of uterine cervical carcinoma].
Sakamoto Y; Kamada M; Kishi Y; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2090-6. PubMed ID: 3908586
[TBL] [Abstract][Full Text] [Related]
15. [Distribution of oncotrophoblast antigens defined by monoclonal antibodies].
Inoue R
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1837-43. PubMed ID: 3209911
[TBL] [Abstract][Full Text] [Related]
16. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
17. Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma.
Tsuji Y; Yoshioka M; Ogasawara T; Takemura T; Isojima S
Cancer Res; 1987 Jul; 47(13):3543-50. PubMed ID: 2438039
[TBL] [Abstract][Full Text] [Related]
18. Identification of beta-oncofetal antigen in cervical squamous cancer and its demonstration in neoplastic and normal tissues.
Goldenberg DM; Garner TF; Pant KD; van Nagell JR
Cancer Res; 1978 May; 38(5):1246-9. PubMed ID: 76510
[TBL] [Abstract][Full Text] [Related]
19. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
[TBL] [Abstract][Full Text] [Related]
20. [Cross-reacting epithelial antigen of ectodermal origin in mouse tumors].
Beletskaia LV; Gnezditskaia EV; Raĭkhlin NT; Borodniuk NA; Rassokhina II
Vopr Onkol; 1977; 23(10):83-7. PubMed ID: 74128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
